Skip to main content
SpringerLink
Log in

Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1), a type-II Golgi transmembrane protein of unknown function, is up-regulated in many cancers. Its Golgi luminal domain is potentially the major functional domain. The goal of this study is to identify the proteins interacting with GOLPH2. Using secretory GOLPH2 (sGOLPH2, amino acid residues 55–401) as bait, secretory clusterin (sCLU) was identified as one interacting candidate by yeast two-hybrid screening, and the coiled-coil domain of GOLPH2 was found to be sufficient for interaction with sCLU. The interaction between GOLPH2 and sCLU was confirmed intracellularly and extracellularly. The intracellular co-localization of GOLPH2 and sCLU in Golgi was also shown. These results can help in understanding the biological and pathological significance of GOLPH2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kristiansen G, Fritzsche FR, Wassermann K, Jager C, Tolls A, Lein M, Stephan C, Jung K, Pilarsky C, Dietel M, Moch H (2008) GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer 99:939–948. doi:10.1038/sj.bjc.6604614

    Article  CAS  PubMed  Google Scholar 

  2. Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, Hosford D et al (2008) Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 65:45–53. doi:10.1001/archneurol.2007.3

    Article  PubMed  Google Scholar 

  3. Kladney RD, Bulla GA, Guo L, Mason AL, Tollefson AE, Simon DJ, Koutoubi Z, Fimmel CJ (2000) GP73, a novel Golgi-localized protein upregulated by viral infection. Gene 249:53–65. doi:10.1016/S0378-1119(00)00136-0

    Article  CAS  PubMed  Google Scholar 

  4. Fritzsche FR, Riener MO, Dietel M, Moch H, Jung K, Kristiansen G (2008) GOLPH2 expression in renal cell cancer. BMC Urol 8:15. doi:10.1186/1471-2490-8-15

    Article  PubMed  Google Scholar 

  5. Hu JS, Wu DW, Liang S and Miao XY (2009) GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population. Med Oncol doi:10.1007/s12032-009-9215-y

  6. Bachert C, Fimmel C, Linstedt AD (2007) Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma. Traffic 8:1415–1423. doi:10.1111/j.1600-0854.2007.00621.x

    Article  CAS  PubMed  Google Scholar 

  7. Wright LM, Yong S, Picken MM, Rockey D, Fimmel CJ (2009) Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2). Int J Clin Exp Pathol 2:34–47

    PubMed  Google Scholar 

  8. Shannan B, Seifert M, Leskov K, Willis J, Boothman D, Tilgen W, Reichrath J (2006) Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ 13:12–19. doi:10.1038/sj.cdd.4401779

    Article  CAS  PubMed  Google Scholar 

  9. Jones SE, Jomary C (2002) Clusterin. Int J Biochem Cell Biol 34:427–431. doi:10.1016/S1357-2725(01)00155-8

    Article  CAS  PubMed  Google Scholar 

  10. Behrens P, Jeske W, Wernert N, Wellmann A (2001) Downregulation of clusterin expression in testicular germ cell tumours. Pathobiology 69:19–23. doi:10.1159/000048753

    Article  CAS  PubMed  Google Scholar 

  11. Gu Y, Chen W, Zhao Y, Chen L, Peng T (2009) Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases. Ann Clin Biochem 46:38–43

    Article  CAS  PubMed  Google Scholar 

  12. Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ (2002) Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology 35:1431–1440. doi:10.1053/jhep.2002.32525

    Article  CAS  PubMed  Google Scholar 

  13. Hogasen K, Homann C, Mollnes TE, Graudal N, Hogasen AK, Hasselqvist P, Thomsen AC, Garred P (1996) Serum clusterin and vitronectin in alcoholic cirrhosis. Liver 16:140–146. doi:10.1111/j.1600-0676.1996.tb00719.x

    CAS  PubMed  Google Scholar 

  14. Riener MO, Stenner F, Liewen H, Soll C, Breitenstein S, Pestalozzi BC, Samaras P, Probst-Hensch N, Hellerbrand C, Mullhaupt B, Clavien PA, Bahra M, Neuhaus P, Wild P, Fritzsche F, Moch H, Jochum W, Kristiansen G (2009) Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology 49:1602–1609. doi:10.1002/hep.22843

    Article  CAS  PubMed  Google Scholar 

  15. Wright LM, Huster D, Lutsenko S, Wrba F, Ferenci P, Fimmel CJ (2009) Hepatocyte GP73 expression in Wilson disease. J Hepatol 51:557–564. doi:10.1016/j.jhep.2009.05.029

    Article  CAS  PubMed  Google Scholar 

  16. Panico F, Rizzi F, Fabbri LM, Bettuzzi S, Luppi F (2009) Clusterin (CLU) and lung cancer. Adv Cancer Res 105:63–76. doi:10.1016/S0065-230X(09)05004-0

    Article  CAS  PubMed  Google Scholar 

  17. Lau SH, Sham JS, Xie D, Tzang CH, Tang D, Ma N, Hu L, Wang Y, Wen JM, Xiao G, Zhang WM, Lau GK, Yang M, Guan XY (2006) Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene 25:1242–1250. doi:10.1038/sj.onc.1209141

    Article  CAS  PubMed  Google Scholar 

  18. Ghiggeri GM, Bruschi M, Candiano G, Rastaldi MP, Scolari F, Passerini P, Musante L, Pertica N, Caridi G, Ferrario F, Perfumo F, Ponticelli C (2002) Depletion of clusterin in renal diseases causing nephrotic syndrome. Kidney Int 62:2184–2194. doi:10.1046/j.1523-1755.2002.00664.x

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Science Foundation (309701647), the National Basic Research Program (973) (2009CB522300, 2010CB530100), and the Science and Technology Program of Guangzhou, China (2007Z1-E0111).

Author information

Author notes

  1. Tao Peng

    Present address: Guangzhou Institute of Biomedicine and Health, #190 Kai Yuan Avenue, Guangzhou Science Park, 510530, People’s Republic of China

Authors and Affiliations

  1. State Key Laboratory of Respiratory Diseases, Laboratory of Viral Immunology, Guangzhou Institute of Biomedicine and Health (GIBH), Chinese Academy of Sciences, Guangzhou, 510530, People’s Republic of China

    Yan Zhou, Leike Li, Longbo Hu & Tao Peng

  2. University of Science and Technology of China, Hefei, 230026, People’s Republic of China

    Yan Zhou, Leike Li & Tao Peng

Authors
  1. Yan Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leike Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Longbo Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tao Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tao Peng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhou, Y., Li, L., Hu, L. et al. Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin. Mol Biol Rep 38, 1457–1462 (2011). https://doi.org/10.1007/s11033-010-0251-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-010-0251-7

Keywords

Search

Navigation